SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
ChemoCentryx, Inc. to Report Data for CCX140, an Orally Administered CCR2 Inhibitor, at the American Society of Nephrology's Kidney Week 2012